Simple Science

Cutting edge science explained simply

# Biology# Neuroscience

KAT8's Role in Parkinson's Disease and Mitochondrial Health

Study highlights KAT8's impact on mitochondrial cleanup in Parkinson's disease.

― 6 min read


KAT8: Key toKAT8: Key toMitochondrial CleanupParkinson's disease mechanisms.Research unveils KAT8's influence on
Table of Contents

Parkinson's Disease (PD) is a disorder that affects movement. Some cases are inherited, while others develop without a clear family link. Researchers have studied specific genetic forms of PD to learn more about how the disease works. Some of these genetic changes happen in genes that control how cells clean up damaged parts, particularly the mitochondria, which are the parts of the cell that make energy. Two important genes, PINK1 and Parkin, play a big role in this process. When these genes do not work properly, it can lead to problems with clearing out damaged mitochondria, which is an important factor in familial PD.

The Role of Mitochondria in Health

Mitochondria are vital for various functions in our cells. They produce energy, help maintain calcium levels, manage harmful substances, and even control cell death. Damage to mitochondria can lead to the release of toxic substances that can kill cells or make them sick. Therefore, keeping mitochondria healthy is crucial. Cells have ways to identify and remove damaged mitochondria to prevent further harm.

Understanding PINK1 and Parkin in Mitophagy

The process of cleaning up damaged mitochondria is called mitophagy. PINK1 and Parkin are key players in this cleanup. Under normal conditions, PINK1 levels are low, but when mitochondria are damaged, PINK1 builds up on their surface. This buildup activates PINK1, which then signals Parkin to come and attach itself to the damaged mitochondria. Parkin tags these dysfunctional mitochondria for removal, allowing the cell to dispose of them properly. This process involves marking proteins on the outer membrane of the mitochondria, which helps the cell recognize what needs to be cleaned.

How the Disease Affects Mitochondrial Cleanup

Research has shown that in some common cases of PD, the pathways involving PINK1 may not work correctly. Genes associated with these common forms of PD have been linked to problems in the PINK1 and Parkin system. Studies suggest that certain enzymes that add or remove chemical tags from proteins can influence how well this cleanup process works. One such enzyme is KAT8, which is important for modifying proteins involved in gene expression and mitochondrial function.

The Role of KAT8 in Mitochondrial Maintenance

KAT8 is involved in adding a chemical group (acetylation) to proteins, which can change how those proteins behave. By modifying proteins, KAT8 can influence many cellular processes, including mitophagy. Inhibition of KAT8 has been studied in several contexts, including cancer and neurodegenerative diseases. The dual inhibitor MG149 targets KAT8 and another enzyme called KAT5. Researchers are interested in how MG149 affects the process of mitophagy, specifically looking at its impact on PINK1 and Parkin.

Observations from MG149 Treatment

When researchers treated cells with MG149, they noticed two main effects:

  1. Inhibition of Mitophagy Initiation: MG149 reduced the activity needed to start the cleanup of damaged mitochondria. Specifically, it lowered the activation of PINK1, which is necessary for the first steps in the mitigation process.

  2. Increase in Delivery to Lysosomes: Interestingly, MG149 also caused an increase in the movement of damaged mitochondria towards lysosomes, which are the cell’s disposal units. This suggests an interesting link between KAT8 inhibition and the broader functioning of the cell.

Experimenting with Cell Cultures

To study these effects in detail, researchers used a type of human nerve cell line known as SH-SY5Y. They treated these cells with MG149 and measured different markers involved in the mitophagy process. The results were promising and indicated that while MG149 lowered the initiation of mitophagy, it still allowed for the movement of mitochondria towards lysosomes.

Evaluating Mitophagy Markers

When assessing the effects of MG149 on mitophagy, scientists measured specific markers. One important marker is called pUb(Ser65), which shows the tagging of damaged mitochondria. In experiments, cells treated with MG149 showed reduced levels of this marker, indicating a decrease in the initiation of mitophagy. Even though this inhibition occurred, MG149 did not stop the movement of mitochondria to lysosomes, illustrating that the cleanup process could still continue in a limited manner.

The Impact of MG149 on Mitochondrial Function

Another area of interest was the effect of MG149 on mitochondrial membrane potential, which is crucial for mitochondrial function. The researchers found that MG149 actually caused depolarization of the mitochondrial membrane. This means that even without inducing damage through other treatments, MG149 itself could affect how well the mitochondria operate.

KAT8 and PINK1 Interaction

KAT8 is believed to influence PINK1 activity. When researchers looked at PINK1’s phosphorylation (a process that activates proteins), they found that MG149 decreased the autophosphorylation of PINK1. This reduction affects PINK1's ability to initiate mitophagy properly. While MG149 did not significantly change the levels of PINK1 RNA or the overall PINK1 protein, it notably impacted how well PINK1 could carry out its functions.

The Role of Autophagy Adapters

In the cleanup process, certain proteins called autophagy adapters play a role in binding to damaged mitochondria and facilitating their removal. One such adapter is p62, which can recognize the tagged mitochondria and help form autophagosomes (the structures that engulf and transport waste). The experiments found that while MG149 didn’t prevent the binding of p62 to mitochondria when there was no mitochondrial damage, inhibiting KAT8 did change how effective this process was.

Implications for Parkinson's Disease and Treatment

The findings highlight the complex role of KAT8 in regulating PINK1 and promoting proper mitochondrial function. Since defects in these pathways are linked to diseases like PD, understanding how KAT8 inhibitors like MG149 affect these processes could lead to new treatment approaches. By targeting specific enzymes involved in the regulation of mitophagy, there may be potential for therapies that improve mitochondrial cleanup, which could alleviate some symptoms of neurodegenerative diseases.

Future Directions in Research

Research into the effects of KAT8 continues to be important, especially as it relates to different diseases. Further studies could help clarify how KAT8 and related enzymes influence mitochondria and overall cell health. Novel treatments targeting KAT8 could offer protective effects against neurodegenerative diseases, and ongoing research may pave the way for new strategies in combating conditions like Parkinson’s Disease.

Conclusion

In summary, the study of KAT8’s role in mitochondrial maintenance has opened up new avenues for understanding and treating conditions like Parkinson’s Disease. By examining how MG149 impacts mitochondrial processes, researchers are uncovering vital information that may lead to more effective therapies for those affected by neurodegenerative diseases.

Original Source

Title: KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy

Abstract: It has recently been shown that KAT8, a genome-wide association study (GWAS) candidate risk gene for Parkinsons Disease, is involved in PINK1/Parkin-dependant mitophagy. The KAT8 gene encodes a lysine acetyltransferase and represents the catalytically active subunit of the non-specific lethal (NSL) epigenetic remodelling complex. In the current study, we show that contrary to KAT5 inhibition, dual inhibition of KAT5 and KAT8 via the MG149 compound inhibits the initial steps of the PINK1-dependant mitophagy process. More specifically, our study shows that following mitochondrial depolarisation induced by mitochondrial toxins, MG149 treatment inhibits PINK1-dependant mitophagy initiation by impairing PINK1 activation, and subsequent phosphorylation of Parkin and ubiquitin. While this inhibitory effect of MG149 on PINK1-activation is potent, MG149 treatment in the absence of mitochondrial toxins is sufficient to depolarise the mitochondrial membrane, recruit PINK1 and promote partial downstream recruitment of the autophagy receptor p62, leading to an increase in mitochondrial delivery to the lysosomes. Altogether, our study provides additional support for KAT8 as a regulator of mitophagy and autophagy processes.

Authors: Helene Plun-Favreau, C. de Talhouet, N. Esteras Gallego, M. P. M. Soutar, B. O'Callaghan

Last Update: 2024-01-31 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2023.08.03.551835

Source PDF: https://www.biorxiv.org/content/10.1101/2023.08.03.551835.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

Similar Articles